Skip to main content

Advertisement

SpringerLink
Log in

Differences in HPV Immunization Levels Among Young Adults in Various Regions of the United States

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

HPV vaccine uptake in young adult women in the Southern US has been previously found to be the lowest in the country. In addition, geographic variation with regard to HPV vaccination among young adult men has not been investigated yet. The objective of this study was to use the most recent data to determine if inequality still exists. We used Behavioral Risk Factor Surveillance System 2012 data from 8 states (no data available from Midwest) to examine the geographic variations in weighted proportion of adults who initiated (≥1 dose) and completed (3 doses) the HPV vaccine among 3727 young adults (2014 women and 1713 men) 18–26 years old based on self-reported HPV vaccination and socio-demographic characteristics. The weighted vaccine initiation and completion rates among men were: 6.3 and 1.7 % overall, 8.5 and 2.2 % in the Northeast, 6.7 and 1.6 % in the West, and 4.9 and 1.4 % in the South (p = 0.184 and 0.774). The rates among women were: 40.4 % and 27.4, 58.7 and 45.6 %, 39.0 and 24.8 %, and 30.4 and 17.7 % in the respective regions (p < 0.001 for both). Adjusted multivariable logistic regression showed that women living in the South and West were less likely to initiate and complete the 3-dose HPV vaccine series when compared to those in the Northeast. Despite an increase in HPV vaccine uptake among young adult women in all regions, geographic disparity still exists. Moreover, young adult men had very low HPV vaccine initiation and completion rates throughout the US.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 56, 1–24.

    Google Scholar 

  2. Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendation from the Advisory Committee on Immunization Practices (ACIP). MMWR, 59, 626–629.

    Google Scholar 

  3. Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., et al. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine, 356, 1928–1943.

    Article  CAS  PubMed  Google Scholar 

  4. Paavonen, J., Naud, P., Salmeron, J., Wheeler, C. M., Chow, S. N., et al. (2009). Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet, 374, 301–314.

    Article  CAS  PubMed  Google Scholar 

  5. Laz, T. H., Rahman, M., & Berenson, A. B. (2013). Human papillomavirus vaccine uptake among 9–17 year old males in the United States: The National Health Interview Survey, 2010. Human vaccines and immunotherapeutics, 9, 874–878.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Giuliano, A. R., Tortolero-Luna, G., Ferrer, E., Burchell, A. N., de Sanjose, S., et al. (2008). Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine, 26(Suppl 10), K17–K28.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24(3), S3/35–S3/41.

    Article  Google Scholar 

  8. Williams, W. W., Lu, P. J., O’Halloran, A., Bridges, C. B., Pilishvili, et al. (2014). Centers for Disease Control and Prevention (CDC). Noninfluenza vaccination coverage among adults-United States, 2012. MMWR Morbidity and Mortality Weekly Report, 63, 95–102.

    PubMed  Google Scholar 

  9. Rahman, M., Laz, T. H., & Berenson, A. B. (2013). Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008–2010: National Health Interview Survey, 2010. Vaccine, 31, 5495–5499.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Mokdad, A. H. (2009). The behavioral risk factors surveillance system: Past, present, and future. Annual Review of Public Health, 30, 43–54.

    Article  PubMed  Google Scholar 

  11. Centers for Disease Control and Prevention (CDC). (2012). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention (also Available at http://www.cdc.gov/brfss/annual_data/2012/response_rates_12.htm).

  12. Centers for Disease Control and Prevention (CDC). (2012). Behavioral risk factor surveillance system survey questionnaire. Atlanta, Georgia: Department of Health and Human Services, Centers for Disease Control and Prevention.

    Google Scholar 

  13. Watson, M., Saraiya, M., Ahmed, F., Cardinez, C. J., Reichman, M. E., et al. (2008). Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods. Cancer, 113(10 Suppl.), 2841–2854.

    Article  PubMed  Google Scholar 

  14. Laz, T. H., Rahman, M., & Berenson, A. B. (2013). Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States during 2008–2010. Cancer, 119, 1386–1392.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Wei, F., Moore, P. C., & Green, A. L. (2013). Geographic variability in human papillomavirus vaccination among US young women. American Journal of Preventive Medicine, 44, 154–157.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Price, R. A., Tiro, J. A., Saraiya, M., Meissner, H., & Breen, N. (2011). Use of human papillomavirus vaccines among young adult women in the United States: An analysis of the 2008 National Health Interview Survey. Cancer, 117, 5560–5568.

    Article  PubMed Central  Google Scholar 

  17. Chao, C., Velicer, C., Slezak, J. M., & Jacobsen, S. J. (2010). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171, 357–367.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Renwick, T. (2011). Geographic Adjustments of supplemental poverty measure thresholds: Using the American community survey five-year data on housing costs. US Census Bureau. SEHSD Working Paper Number 2011–21 Available at https://www.census.gov/hhes/povmeas/methodology/supplemental/research/RenwickGeographicAdjustmentsJuly2011WEA.pdf.

  19. Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of women’s health, 18, 1679–1686.

    Article  PubMed  Google Scholar 

  20. Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., et al. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007. Preventive Medicine, 48, 426–431.

    Article  PubMed  Google Scholar 

  21. Tylor, L. D., Harriri, S., Sternberg, M., Dunne, E. F., & Markowitz, L. E. (2011). Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008. Preventive Medicine, 52, 398–400.

    Article  Google Scholar 

  22. Schluterman, N. H., Terplan, M., Lydecker, A. D., & Tracy, J. K. (2011). Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine, 29, 3767–3772.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Center for Interdisciplinary Research in Women’s Health, University of Texas Medical Branch, 301 University Blvd., Galveston, TX, 77555-0587, USA

    Mahbubur Rahman, Momin Islam & Abbey B. Berenson

Authors
  1. Mahbubur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Momin Islam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abbey B. Berenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahbubur Rahman.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahman, M., Islam, M. & Berenson, A.B. Differences in HPV Immunization Levels Among Young Adults in Various Regions of the United States. J Community Health 40, 404–408 (2015). https://doi.org/10.1007/s10900-015-9995-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-015-9995-2

Keywords

Search

Navigation